Bonato, PhD, MA, RPSGT, is the CEO and Co-Founder of BRAEBON ® Medical. Richard has been involved in the study of sleep and its disorders since 1986. He has taught courses on Sleeping & Dreaming at Carleton University in Ottawa Canada and has lectured on sleep medicine and technology on four continents worldwide. Validation Study Evaluation of a portable monitor compared with polysomnography for the diagnosis of obstructive sleep apnea, 2009, Helen S Driver, PhD et al. Download DentiTrac Introducing DentiTrac ® Sleep Diagnosis and Therapy 2013; V8 N3, 12-15, Richard A. Bonato, Ph.D., Donald C.
DUBLIN--(BUSINESS WIRE)--The 'Global Emerging Sleep Apnea Devices and Platforms Market: Analysis and Forecast, 2021-2030' report has been added to ResearchAndMarkets.com's offering.
The overall market was estimated to be $4,882.2 million in FY2019, and it is expected to grow at a CAGR of 9.94% during the forecast period, 2021-2030.
The global emerging sleep apnea devices and platforms market is witnessing an exponential rise in the size of the market due to the ongoing COVID-19 pandemic. Presently, more than 45 companies are operating in this market, including already existing healthcare companies and emerging healthcare companies.
Moreover, during COVID-19 pandemic, various regulatory agencies such as Food and Drug Administration (FDA), U.S. and Therapeutic Goods Administration (TGA) have approved the usage of positive airway pressure (PAP) devices such as continuous positive airway pressure (CPAP) devices, bilevel positive airway pressure (BPAP) devices, and adaptive servo ventilators (ASVs) as ventilators. Additionally, the demand for oral appliances has also increased significantly due to the high risk of infection in the case of COVID-19 positive sleep apnea patients.
In the situation, the usage of a PAP device can increase the risk of infection for the patient's peers. Other devices with increased demand included home sleep testing devices and sleep apnea screening and monitoring devices and solutions. In addition to conventional devices, emerging therapeutic and diagnostic and monitoring devices have also witnessed a significant increase in demand.
Healthcare experts are continuously analyzing the impact of regulatory and industrial decisions on the global emerging sleep apnea devices and platforms market. The market is driven by certain factors, including growing awareness regarding the ill effects of untreated sleep apnea, increasing usage of oral appliances for sleep apnea treatment, rising demand for portable sleep apnea devices, and technological advancements in sleep apnea treatment and diagnosis devices and platforms.
The market is favored by the development of emerging therapeutics and diagnostic, monitoring devices and solutions, and increasing adoption of the sleep apnea devices.
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/1zphsa
DUBLIN--(BUSINESS WIRE)--The 'North America Sleep Apnea Devices Market, by Product Type, by Therapeutic Devices Type, by Diagnostic Devices Type, by Country, Industry Analysis and Forecast, 2019 - 2025' report has been added to ResearchAndMarkets.com's offering.
The North America Sleep Apnea Devices Market is expected to witness market growth of 6.6% CAGR during the forecast period (2019-2025).
Positive airway pressure therapy (PAP) is the most commonly used treatment for sleep apnea. The airway opening is controlled via PAP device with a nose mask or similar device. Using PAP system raises energy levels, boosts mood, mental alertness and sleep efficiency. The face mask is linked to a tube and a pump that helps to hold it open by moving pressurized air into the airway. Biology field advancements have similarly improved the numerous medical devices, such as sleep apnea devices and others. In the last several years many industry players have developed innovative types of sleep apnea products.
North America currently dominates the sleep apnea devices market, and its dominance is anticipated to continue for a few more years. Because of the high incidence of sleep-disordered breathing (SDB) and increasing geriatric population in the region, North American countries are expected to raise their market share in future. The US held a majority share of the market. According to the American Sleep Association, an estimated 50-70 million adults in the United States were found to have a sleep disorder as of 2018, 48 percent were reported to have snoring, 37.9 percent were reported to have fallen asleep during the day, accidentally, and 4.7 percent were reported to have nodded off while driving.
Based on Product Type, the market is segmented into Therapeutic Devices and Diagnostic Devices. Based on Therapeutic Devices Type, the market is segmented into PAP Devices, Oral Devices, Nasal Devices and Chin Straps. Based on Diagnostic Devices Type, the market is segmented into Polysomnography, Respiratory Polygraphs, Pulse Oximeters and Actigraphs. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Companies Profiled
Unique Offerings from the Publisher
Key Topics Covered:
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2015, Sep - 2020, Feb) Leading Players
3.3.3 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2015, Jun - 2019, Oct) Leading Players
Chapter 4. North America Sleep Apnea Devices Market by Product Type
4.1 North America Therapeutic Devices Market by Country
4.1.1 North America Therapeutic Devices Market by Devices Type
4.1.1.1 North America PAP Devices Market by Country
4.1.1.2 North America Oral Devices Market by Country
4.1.1.3 North America Nasal Devices Market by Country
4.1.1.4 North America Chin Straps Market by Country
4.2 North America Diagnostic Devices Market by Country
4.2.1 North America Diagnostic Devices Market by Devices Type
4.2.1.1 North America Polysomnography Market by Country
4.2.1.2 North America Respiratory Polygraphs Market by Country
4.2.1.3 North America Pulse Oximeters Market by Country
4.2.1.4 North America Actigraphs Market by Country
Chapter 5. North America Sleep Apnea Devices Market by Country
5.1 USA Sleep Apnea Devices Market
5.1.1 USA Sleep Apnea Devices Market by Product Type
5.1.1.1 USA Therapeutic Devices Market by Devices Type
5.1.1.2 USA Diagnostic Devices Market by Devices Type
5.2 Canada Sleep Apnea Devices Market
5.2.1 Canada Sleep Apnea Devices Market by Product Type
5.2.1.1 Canada Therapeutic Devices Market by Devices Type
5.2.1.2 Canada Diagnostic Devices Market by Devices Type
5.3 Mexico Sleep Apnea Devices Market
5.3.1 Mexico Sleep Apnea Devices Market by Product Type
5.3.1.1 Mexico Therapeutic Devices Market by Devices Type
5.3.1.2 Mexico Diagnostic Devices Market by Devices Type
5.4 Rest of North America Sleep Apnea Devices Market
5.4.1 Rest of North America Sleep Apnea Devices Market by Product Type
5.4.1.1 Rest of North America Therapeutic Devices Market by Devices Type
5.4.1.2 Rest of North America Diagnostic Devices Market by Devices Type
Chapter 6. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/kr1icn